Review Article

Factors Associated with Late Local Radiation Toxicity after Post-Operative Breast Irradiation

Table 3

Overview of different domains of late radiation toxicity in relation to the summarized risk factors.

StudyRadiotherapySurgery and systemic treatmentPatient characteristicsOthera
Increased dose or irradiated volumeRT boost (dose)Acute toxicityRT- surgery intervalSurgical complicationsALNDEndocrine therapyChemotxOther LRT symptomsAgeBreast volumeTumor locationBMIDiabetes mellitus

GRTCiamellaS/NSbS/NSbNSS/NSbNSNSNSNS
de roseS
de rose (2020)NSSNSNSNSSS
DigesuSNSNSNS/ScS
HannanSSSS
HosniSNSS
KellerSSSS
LazzariSNSNSS
PalumboNSNSNSNSNSNS
YuNSSNSNSS/NS
PainBarnettSSSS
de rose (2020)NSNSNS
Hille-betzNSS
IshiyamaSNSNSNSNSNS
Breast fibrosisBergomNSNSNSNSNSNS
BronsartS/NSNSNSNS
de santisNSNSNSNSNS
Hille-betzNSSNSS
IshiyamaNSSNSNSNSNS
JosephNSNSNSNSSNS
KelemenSSSS
LillaSS
MeattiniNSSSS/NS
La roccaSNSNS
Breast or arm edemaBarnettSSSS
Hille-betzNSNSSSNSNS
IshiyamaNSNSSNSSNS
KelemenSS
KellerSSSS
MeattiniSS/NScNSNS
La roccaSNSNS

aDepending on boost/no boost group. bDepending on subacute or skin toxicity respectively. cDepending on administered dose; Abbreviations: BMI body mass index; Chemotx chemotherapy; GRT late radiation toxicity; LRT late radiation toxicity; NS no significant association, RT radiotherapy; S significant association; Association not studied.